Check out the ACC.19 Meeting Coverage Page for post-meeting content on valvular heart disease (VHD) to reinforce the teaching points and education presented during ACC.19.

In a recent expert analysis, Ahmad Masri, MD, et al., review and discuss key findings from the hottest trials on VHD, including PARTNER 3, Evolut Low Risk, COAPT-QoL, POET and others. Read more.

View additional learning pathway presentations in iScience, the ACC.19 Meeting on Demand^™ Program.

Stay tuned as more content will be added to the ACC.19 Meeting Coverage Page.